Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 28, 2018; 24(4): 494-503
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.494
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.494
Figure 2 A 60-year-old woman with moderately differentiated hepatocellular carcinoma positive for GPC3 expression (A-E) and a 38-year-old man with poorly differentiated HCC negative for GPC3 (G-J).
A-C: 18F-FDG PET/CT showed slight 18F-FDG uptake (SUVmax = 3.4, T/NT = 1.54) in the tumour (black arrow in A, white arrows in B and C). D: Moderately differentiated hepatocellular carcinoma (HCC) was diagnosed by pathological examination using HE staining. E: Immunohistochemical analysis revealed positive expression of GPC3. F: Immunohistochemical analysis revealed low expression of GLUT1 in tumour tissue. G-I: 18F-FDG PET/CT scans showed intense accumulation of 18F-FDG (SUVmax = 16.5, T/NT = 7.03) in the tumour (black arrow in G, white arrows in H and I). J: Poorly differentiated HCC was confirmed by pathological examination using HE staining. K: Immunohistochemical analysis revealed that the tumour was negative for GPC3 expression. L: Immunohistochemical analysis revealed high GLUT1 expression in tumour tissue.
- Citation: Li YC, Yang CS, Zhou WL, Li HS, Han YJ, Wang QS, Wu HB. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression. World J Gastroenterol 2018; 24(4): 494-503
- URL: https://www.wjgnet.com/1007-9327/full/v24/i4/494.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i4.494